Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy

Epilepsy Research

Volumn 70, Issue 2-3, 2006, Pages 211-217

  Voudris, Konstantinos A ^a   Attilakos, Achilleas ^b   Katsarou, Eustathia ^a   Drakatos, Antonios ^a   Dimou, Stamatia ^a   Mastroyianni, Sotiria ^a   Skardoutsou, Angeliki ^b   Prassouli, Alexia ^b   Garoufi, Anastasia ^b  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Carbamazepine; Epileptic children; Serum lipids; Serum lipoprotein (a); Serum lipoproteins; Sodium valproate

Indexed keywords

ANTICONVULSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBAMAZEPINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VALPROIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; EPILEPSY; FEMALE; HUMAN; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; MALE; MEASUREMENT; MENTAL CONCENTRATION; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; PROSPECTIVE STUDIES; TIME FACTORS; VALPROIC ACID;

EID: 33746884341     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.05.002     Document Type: Article

References (24)

1. Al-Waili, N.S., Al-Waili, H., Saloom, K.Y., Al-Waili, T., Al-Waili, A., Akmal, M., Al-Waili, F., 2006. Effect of carbamazepine on urinary volume and osmolality, water clearance, and serum osmolality in patients with primary enuresis. Eur. Urol. doi:10.1016/j.eururo.2006.02.040.
2. Aynaci F.M., Orhan F., Orem A., Yildirmis S., and Gedik Y. Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. J. Child Neurol. 16 (2001) 367-369
3. Bostom A.G., Cupples L.A., Jenner J.L., Ordovas J.M., Seman L.J., Wilson P.W., Schaefer E.J., and Castelli W.P. Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 276 (1996) 544-548
4. Bramswig S., Sudhop T., Luers C., von Bergmann K., and Berthold H.K. Lipoprotein (a) concentration increases during treatment with carbamazepine. Epilepsia 44 (2003) 457-460
5. Calandre E.P., Rodriguez-Lopez C., Blazquez A., and Cano D. Serum lipids, lipoproteins, and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol. Scand. 83 (1991) 250-253
6. Castro-Gago M., Novo-Rodriguez M.I., Blanco-Barca M.O., Urisarri-Ruiz de Cortazar A., Rodriguez-Garcia J., Rodriguez-Segade S., and Eiris-Punal J. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. J. Child Neurol. 21 (2006) 48-52
7. Eiris J., Novo-Rodriguez M.I., Del Rio M., Meseguer P., Del Rio M.C., and Castro-Gago M. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 41 (2000) 1-7
8. Eiris J.M., Lojo S., Del Rio M.C., Novo I., Bravo M., Pavon P., and Castro-Gago M. Effect of long-term treatment with antiepileptic drugs on serum lipids levels in children with epilepsy. Neurology 45 (1995) 1155-1157
9. Franzoni E., Govoni M., D'Addato S., Gualandi S., Sangiorgi Z., Descovich G.C., and Salvioli G.P. Total cholesterol, high-density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs. Epilepsia 33 (1992) 932-935
10. Isojarvi J.I., Huuskonen U.E., Pakarinen A.J., Vuolteenaho O., and Myllyla V.V. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. Epilepsia 42 (2001) 741-745
11. Isojarvi J.I., Pakarinen A.J., and Myllyla V.V. Serum lipid levels during carbamazepine medication. A prospective study. Arch. Neurol. 50 (1993) 590-593
12. Kim C.J., Ryu W.S., Kwak J.W., Park C.T., and Ryoo U.H. Changes in Lp (a) lipoprotein and lipids levels after cessation of female sex hormonal production and estrogen replacement therapy. Arch. Int. Med. 156 (1996) 500-504
13. Mahmoudian T., Iranpour R., and Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav. 6 (2005) 257-259
14. Orth-Gomer K., Mittleman M.A., Schenck-Gustafsson K., Wamala S.P., Eriksson M., Belkic K., Kirkeeide R., Svane B., and Ryden L. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 95 (1997) 329-334
15. Rigla M., Sanchez-Quesada J.L., Ordonez-Llanos J., Prat T., Caixas A., Jorba O., Serra J.R., de Leiva A., and Perez A. Effect of physical exercise on lipoprotein (a) and low density lipoprotein modifications in type 1 and 2 diabetic patients. Metabolism 49 (2000) 640-647
16. Schwaninger M., Ringleb P., Annecke A., Winter R., Kohl B., Werle E., Fiehn W., Rieser P.A., and Walter S. Elevated plasma concentrations of lipoprotein (a) in medicated epileptic patients. J. Neurol. 247 (2000) 687-690
17. Sonmez F.M., Demir E., Orem A., Yildirmis S., Orhan F., Aslan A., and Topbas M. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J. Child Neurol. 21 (2006) 70-74
18. Sozuer D.T., Atakil D., Dogu O., Baybas S., and Arpaci B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur. J. Pediatr. 156 (1997) 565-567
19. Tumer L., Serdaroglu A., Hasanoglu A., Biberoglu G., and Aksoy E. Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants. Acta Paediatr. 91 (2002) 923-926
20. Van Biervliet J.P., Labeur C., Michiels G., Usher D.C., and Rosseneu M. Lipoprotein (a) profiles and evolution in newborns. Atherosclerosis 86 (1991) 173-181
21. Verrotti A., Basciani F., Domizio S., Sabatino G., Morgese G., and Chiarelli F. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr. Neurol. 19 (1998) 364-367
22. Voudris K.A., Attilakos A., Katsarou E., Garoufi A., Dimou S., Skardoutsou A., and Mastroyianni S. Early alteration of bone metabolism in epileptic children receiving carbamazepine monotherapy due to the induction of the hepatic drug-metabolizing enzymes. J. Child Neurol. 20 (2005) 513-516
23. Wang X.L., Wilcken D.E., and Dudman N.P. Early expression of the apolipoprotein (a) gene: relationships between infants' and their parents' serum apolipoprotein (a) levels. Pediatrics 89 (1992) 401-406
24. Willmore L.J., Wilder B.J., Bruni J., and Villarreal H.J. Effect of valproic acid on hepatic function. Neurology 28 (1978) 961-964